Changes in myofascial lesions visible by magnetic resonance imaging from baseline (Week 0) to 12 weeks after tocilizumab therapy initiation.
| Muscle Group | No Change, n (%) | Improvement, n (%) | Worsening, n (%) | Total |
|---|---|---|---|---|
| Shoulders | 11 (39.3) | 15 (53.6) | 2 (7.1) | 28 |
| Hips | 6 (20.0) | 24 (80.0) | 0 (0.0) | 30 |
| Ischial tuberosities | 15 (50.0) | 15 (50.0) | 0 (0.0) | 30 |
| Pubic symphysis | 3 (20.0) | 12 (80.0) | 0 (0.0) | 15 |
| Total | 35 | 66 | 2 | 103 |